Biotech Firm CinCor Pharma Kicks Off Nasdaq IPO Roadshow

Clinical-stage biopharmaceutical company CinCor Pharma, Inc. is setting its sights on trading at the Nasdaq Global Market. The firm announced on Monday the launch of its initial public offering of 11.0 million common shares.

The biotech firm is targeting the share price between US$15.00 and US$17.00 per share, which puts target proceeds from the offering at US$187 million on the high end of the range.

The shares are expected to trade on the Nasdaq big board under the symbol “CINC”. The underwriters also have a 30-day over-allotment option to purchase additional 1.65 million shares.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

The pharmaceutical firm is focused on its lead drug candidate CIN-107, an oral aldosterone synthase inhibitor which makes it a potential treatment for hypertension and other cardio-renal diseases. The drug is currently in two phase 2 clinical trials, one for treatment-resistant hypertension and one for primary aldosteronism.

The company is led by CEO Marc de Garidel, a former CEO and the current board chairman of Euronext Paris-listed pharmaceutical firm Ipsen.


Information for this briefing was found via Edgar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

First Majestic Hits 4.24 g/t Gold Over 48.8 Metres at Saval as Jerritt Canyon Restart Advances

First Majestic Lifts Q3 Revenue 38% to US$394.1 Million on Higher Silver Prices

Related News

Tech SPAC Denali Capital Acquisition Prices US$75 Million IPO

Special purpose acquisition company Denali Capital Acquisition Corp. (Nasdaq: DECAU) started trading publicly on the...

Friday, April 8, 2022, 02:19:00 PM

Tech SPAC Aurora Technology Acquisition Prices US$200 Million IPO

Special purpose acquisition company Aurora Technology Acquisition Corp. (Nasdaq: ATAKU) started trading publicly on the...

Tuesday, February 8, 2022, 02:26:00 PM

Former Tapestry CEOs-Led Consumer SPAC Acacia Blue Prices US$240 Million IPO

Special purpose acquisition company Bleuacacia (Nasdaq: BLEUU), also referred to as Acacia Blue, started trading...

Thursday, November 18, 2021, 02:17:00 PM

Fintech SPAC World Quantum Growth Acquisition Prices Downsized US$200 Million IPO

Blank check company World Quantum Growth Acquisition Corp. (NYSE: WQGA.U) went public yesterday on the...

Thursday, August 12, 2021, 04:37:00 PM

Electric Sports Boat Maker Forza X1 Prices US$15 Million IPO

Recreational boating firm Forza X1 (Nasdaq: FRZA) started trading its shares on the Nasdaq Capital...

Friday, August 12, 2022, 02:10:00 PM